137 related articles for article (PubMed ID: 32378563)
21. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids.
Corli O; Floriani I; Roberto A; Montanari M; Galli F; Greco MT; Caraceni A; Kaasa S; Dragani TA; Azzarello G; Luzzani M; Cavanna L; Bandieri E; Gamucci T; Lipari G; Di Gregorio R; Valenti D; Reale C; Pavesi L; Iorno V; Crispino C; Pacchioni M; Apolone G;
Ann Oncol; 2016 Jun; 27(6):1107-1115. PubMed ID: 26940689
[TBL] [Abstract][Full Text] [Related]
22. [Direct conversion from low-dose morphine to transdermal fentanyl: efficacy for cancer pain and quality of life].
Yamazaki M; Aoki T; Tachibana M; Akashi T
Gan To Kagaku Ryoho; 2006 Feb; 33(2):217-21. PubMed ID: 16484859
[TBL] [Abstract][Full Text] [Related]
23. [Validity of recommended minimum dose of prior morphine to initiate transdermal fentanyl patch in prescribing information - multicenter survey of on prescriptions by palliative care specialists in Japan].
Hashizume T; Tomiyasu S; Yomiya K; Yoshimoto T; Harada A; Matoba M;
Gan To Kagaku Ryoho; 2007 Jun; 34(6):897-902. PubMed ID: 17570968
[TBL] [Abstract][Full Text] [Related]
24. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.
Payne R; Mathias SD; Pasta DJ; Wanke LA; Williams R; Mahmoud R
J Clin Oncol; 1998 Apr; 16(4):1588-93. PubMed ID: 9552070
[TBL] [Abstract][Full Text] [Related]
25. [Effectiveness of switching opioids from fentanyl patch to morphine injection].
Sako A; Kikuchi N; Wada Y; Wakabayashi S
Gan To Kagaku Ryoho; 2013 Apr; 40(4):541-5. PubMed ID: 23848029
[TBL] [Abstract][Full Text] [Related]
26. Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain.
Wolff RF; Aune D; Truyers C; Hernandez AV; Misso K; Riemsma R; Kleijnen J
Curr Med Res Opin; 2012 May; 28(5):833-45. PubMed ID: 22443154
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
[TBL] [Abstract][Full Text] [Related]
28. Dose conversion in opioid rotation from continuous intravenous infusion of morphine hydrochloride injection to fentanyl patch in the management of cancer pain.
Kawano C; Hirayama T; Kuroyama M
Yakugaku Zasshi; 2011 Mar; 131(3):463-7. PubMed ID: 21372544
[TBL] [Abstract][Full Text] [Related]
29. Comparative out-of-hospital mortality of long-acting opioids prescribed for non-cancer pain: A retrospective cohort study.
Chung CP; Dupont WD; Murray KT; Hall K; Stein CM; Ray WA
Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):48-53. PubMed ID: 30003613
[TBL] [Abstract][Full Text] [Related]
30. Indication of Adequate Transdermal Fentanyl Dose in Opioid Switching From Oral Oxycodone in Patients With Cancer.
Matsumura C; Yamada M; Fujihara S; Chisaki Y; Takahashi K; Yano Y
Am J Hosp Palliat Care; 2016 Mar; 33(2):109-14. PubMed ID: 25324418
[TBL] [Abstract][Full Text] [Related]
31. Effect of Opioid Exposure on Efficacy and Tolerability of Sublingual Fentanyl and Subcutaneous Morphine for Severe Cancer Pain Episodes. Secondary Analysis From a Double-Blind Double-Dummy, Randomized Trial.
Ricchini F; Caraceni A; Zecca E; Pigni A; Centurioni F; Manzoni A; Kaasa S; Brunelli C
J Pain Symptom Manage; 2019 Oct; 58(4):587-595. PubMed ID: 31233843
[TBL] [Abstract][Full Text] [Related]
32. Fentanyl Sublingual Tablets Versus Subcutaneous Morphine for the Management of Severe Cancer Pain Episodes in Patients Receiving Opioid Treatment: A Double-Blind, Randomized, Noninferiority Trial.
Zecca E; Brunelli C; Centurioni F; Manzoni A; Pigni A; Caraceni A
J Clin Oncol; 2017 Mar; 35(7):759-765. PubMed ID: 28113021
[TBL] [Abstract][Full Text] [Related]
33. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group.
Ahmedzai S; Brooks D
J Pain Symptom Manage; 1997 May; 13(5):254-61. PubMed ID: 9185430
[TBL] [Abstract][Full Text] [Related]
34. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.
Allan L; Hays H; Jensen NH; de Waroux BL; Bolt M; Donald R; Kalso E
BMJ; 2001 May; 322(7295):1154-8. PubMed ID: 11348910
[TBL] [Abstract][Full Text] [Related]
35. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.
Jeal W; Benfield P
Drugs; 1997 Jan; 53(1):109-38. PubMed ID: 9010652
[TBL] [Abstract][Full Text] [Related]
36. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
[TBL] [Abstract][Full Text] [Related]
37. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
[TBL] [Abstract][Full Text] [Related]
38. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy.
Ripamonti C; Fagnoni E; Campa T; Brunelli C; De Conno F
Support Care Cancer; 2006 May; 14(5):400-7. PubMed ID: 16485087
[TBL] [Abstract][Full Text] [Related]
39. Patient-controlled transdermal fentanyl hydrochloride vs intravenous morphine pump for postoperative pain: a randomized controlled trial.
Viscusi ER; Reynolds L; Chung F; Atkinson LE; Khanna S
JAMA; 2004 Mar; 291(11):1333-41. PubMed ID: 15026400
[TBL] [Abstract][Full Text] [Related]
40. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
